@article{f29eab99acf4463f8a187c79e4aa5839,
title = "Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR-mutated lung cancer and pulmonary tuberculosis: A case report",
abstract = "The concurrent incidence of lung cancer and tuberculosis is expected to escalate due to the projected growth in the older population. Combination therapy with osimertinib and antituberculosis drugs has not been well-established. We report a case of successful treatment involving the concomitant administration of osimertinib and antituberculosis drugs in an older patient, an 89-year-old female, diagnosed with epidermal growth factor receptor (EGFR)-mutant lung cancer and pulmonary tuberculosis. Accumulating evidence is warranted to develop an optimal treatment strategy for patients with lung cancer and tuberculosis.",
keywords = "case report, EGFR-mutated lung cancer, osimertinib, pulmonary tuberculosis, rifampicin",
author = "Hiroaki Matsuura and Hisao Higo and Tadahiro Kuribayashi and Akihiko Tamaoki and Takamasa Nakasuka and Mari Uno and Go Makimoto and Kiichiro Ninomiya and Masanori Fujii and Kammei Rai and Eiki Ichihara and Katsuyuki Hotta and Nobuaki Miyahara and Masahiro Tabata and Yoshinobu Maeda and Katsuyuki Kiura and Kadoaki Ohashi",
note = "Publisher Copyright: {\textcopyright} 2024 The Authors. Thoracic Cancer published by John Wiley & Sons Australia, Ltd.",
year = "2024",
doi = "10.1111/1759-7714.15324",
language = "English",
journal = "Thoracic Cancer",
issn = "1759-7706",
publisher = "Blackwell Publishing Asia Pty Ltd",
}
